Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gastrointestinal Cancer Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gastrointestinal Cancer Drugmarket, defines the market attractiveness level of Gastrointestinal Cancer Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gastrointestinal Cancer Drug industry, describes the types of Gastrointestinal Cancer Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastrointestinal Cancer Drug market and the development prospects and opportunities of Gastrointestinal Cancer Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastrointestinal Cancer Drug market in Chapter 13.
By Player:
Eli Lilly and Company
Johnson & Johnson Private Limited
Celgene Corporation
GlaxoSmithKline plc
Amgen Limited & Amgen Ireland Limited
Pfizer Inc
F Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Novartis AG
Sanofi
By Type:
Immunotherapy
Chemotherapy
Targeted Therapy
Radiation Therapy
Hormone Therapy
Adjuvant Chemotherapy
By End-User:
Radiology
Oncology
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gastrointestinal Cancer Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gastrointestinal Cancer Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gastrointestinal Cancer Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gastrointestinal Cancer Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gastrointestinal Cancer Drug Market Analysis and Outlook to 2022
-
7.1 Global Gastrointestinal Cancer Drug Consumption (2017-2022)
-
7.2 United States Gastrointestinal Cancer Drug Consumption (2017-2022)
-
7.3 Europe Gastrointestinal Cancer Drug Consumption (2017-2022)
-
7.4 China Gastrointestinal Cancer Drug Consumption (2017-2022)
-
7.5 Japan Gastrointestinal Cancer Drug Consumption (2017-2022)
-
7.6 India Gastrointestinal Cancer Drug Consumption (2017-2022)
-
7.7 South Korea Gastrointestinal Cancer Drug Consumption (2017-2022)
8 Region and Country-wise Gastrointestinal Cancer Drug Market Analysis and Outlook to 2028
-
8.1 Global Gastrointestinal Cancer Drug Consumption Forecast (2022-2028)
-
8.2 United States Gastrointestinal Cancer Drug Consumption Forecast (2022-2028)
-
8.3 Europe Gastrointestinal Cancer Drug Consumption Forecast (2022-2028)
-
8.4 China Gastrointestinal Cancer Drug Consumption Forecast (2022-2028)
-
8.5 Japan Gastrointestinal Cancer Drug Consumption Forecast (2022-2028)
-
8.6 India Gastrointestinal Cancer Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Gastrointestinal Cancer Drug Consumption Forecast (2022-2028)
9 Global Gastrointestinal Cancer Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Gastrointestinal Cancer Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Adjuvant Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastrointestinal Cancer Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Radiology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)
10 Global Gastrointestinal Cancer Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Gastrointestinal Cancer Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Adjuvant Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gastrointestinal Cancer Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Radiology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
11 Global Gastrointestinal Cancer Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gastrointestinal Cancer Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gastrointestinal Cancer Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gastrointestinal Cancer Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gastrointestinal Cancer Drug Market Competitive Analysis
-
14.1 Eli Lilly and Company
-
14.1.1 Eli Lilly and Company Company Details
-
14.1.2 Eli Lilly and Company Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly and Company Gastrointestinal Cancer Drug Product and Service
-
14.2 Johnson & Johnson Private Limited
-
14.2.1 Johnson & Johnson Private Limited Company Details
-
14.2.2 Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Product and Service
-
14.3 Celgene Corporation
-
14.3.1 Celgene Corporation Company Details
-
14.3.2 Celgene Corporation Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celgene Corporation Gastrointestinal Cancer Drug Product and Service
-
14.4 GlaxoSmithKline plc
-
14.4.1 GlaxoSmithKline plc Company Details
-
14.4.2 GlaxoSmithKline plc Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline plc Gastrointestinal Cancer Drug Product and Service
-
14.5 Amgen Limited & Amgen Ireland Limited
-
14.5.1 Amgen Limited & Amgen Ireland Limited Company Details
-
14.5.2 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Product and Service
-
14.6 Pfizer Inc
-
14.6.1 Pfizer Inc Company Details
-
14.6.2 Pfizer Inc Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Inc Gastrointestinal Cancer Drug Product and Service
-
14.7 F Hoffmann-La Roche Ltd
-
14.7.1 F Hoffmann-La Roche Ltd Company Details
-
14.7.2 F Hoffmann-La Roche Ltd Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 F Hoffmann-La Roche Ltd Gastrointestinal Cancer Drug Product and Service
-
14.8 Bristol-Myers Squibb Company
-
14.8.1 Bristol-Myers Squibb Company Company Details
-
14.8.2 Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Product and Service
-
14.9 Novartis AG
-
14.9.1 Novartis AG Company Details
-
14.9.2 Novartis AG Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis AG Gastrointestinal Cancer Drug Product and Service
-
14.10 Sanofi
-
14.10.1 Sanofi Company Details
-
14.10.2 Sanofi Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanofi Gastrointestinal Cancer Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gastrointestinal Cancer Drug
-
Figure Gastrointestinal Cancer Drug Picture
-
Table Global Gastrointestinal Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Cancer Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gastrointestinal Cancer Drug Consumption by Country (2017-2022)
-
Figure United States Gastrointestinal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Gastrointestinal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure China Gastrointestinal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastrointestinal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure India Gastrointestinal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastrointestinal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Gastrointestinal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastrointestinal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gastrointestinal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastrointestinal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastrointestinal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastrointestinal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Adjuvant Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiology Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adjuvant Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gastrointestinal Cancer Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gastrointestinal Cancer Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Gastrointestinal Cancer Drug Product and Service
-
Table Johnson & Johnson Private Limited (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Gastrointestinal Cancer Drug Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Gastrointestinal Cancer Drug Product and Service
-
Table Amgen Limited & Amgen Ireland Limited (Foundation Year, Company Profile and etc.)
-
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Gastrointestinal Cancer Drug Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Gastrointestinal Cancer Drug Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Gastrointestinal Cancer Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Gastrointestinal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Gastrointestinal Cancer Drug Product and Service
-
